Sanguinetti v. Forest Laboratories CA1/1

CourtCalifornia Court of Appeal
DecidedJuly 11, 2014
DocketA138400
StatusUnpublished

This text of Sanguinetti v. Forest Laboratories CA1/1 (Sanguinetti v. Forest Laboratories CA1/1) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Sanguinetti v. Forest Laboratories CA1/1, (Cal. Ct. App. 2014).

Opinion

Filed 7/11/14 Sanguinetti v. Forest Laboratories CA1/1 NOT TO BE PUBLISHED IN OFFICIAL REPORTS California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions not certified for publication or ordered published, except as specified by rule 8.1115(b). This opinion has not been certified for publication or ordered published for purposes of rule 8.1115.

IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA

FIRST APPELLATE DISTRICT

DIVISION ONE

GINA SANGUINETTI, Plaintiff and Appellant, A138400 v. FOREST LABORATORIES, INC., et al., (San Francisco City & County Super. Ct. No. CGC-12-518241) Defendants and Respondents.

Gina Sanguinetti sued her former employer, Forest Laboratories, Inc., Forest Pharmaceuticals, Inc. and two of its employees, Brent Newcomb and Willi Toups, (collectively Forest) for gender, age, and disability discrimination under the Fair Employment and Housing Act (Gov. Code, § 12900 et seq.; FEHA). We hold the trial court properly granted summary judgment to Forest because Sanguinetti failed to raise triable issues of material fact with respect to any of her claims. I. BACKGROUND Sanguinetti was hired as a territory sales representative for Forest in 1998. Her duties included calling upon hospitals and pharmacies within her territory to promote Forest’s products. Generating sales was the most important goal in Sanguinetti’s position with Forest. Toups became her division manager and direct supervisor in 2004 and was responsible for periodically riding with Sanguinetti and preparing evaluations of her performance in the field. These evaluations were quantified on a scale of 1 to 5, with 3.0 considered to be the minimum standard performance. Sales representatives also received midyear and annual reviews. From 1998 to mid-2008, Sanguinetti consistently received performance evaluations above 3.0. Sanguinetti had her first child in 2003, and took maternity leave in 2005 to have twins. In fiscal year 2006 (covering April 1, 2005 to March 30, 2006), she ranked 82d in sales among Forest’s 104 hospital sales representatives, and in fiscal year 2007, she ranked 24th. Sanguinetti’s May 2008 performance review (fiscal year 2008 annual review) gave her a 3.43 rating. However, for the nine months ending in December 2007 of that fiscal year, she ranked No. 102 in sales, and the evaluation stated she needed to take immediate action to meet challenges in her territory. Sanguinetti received negative feedback from Toups in July 2008 when she was pregnant with her second set of twins, and about to go on maternity leave. Sanguinetti’s final sales results for the 2008 fiscal year ranked her 103 out of Forest’s 104 hospital representatives nationally. Sanguinetti’s field trip evaluation in July 2008 was 3.07, the lowest rating Toups had given her to that point. The evaluation expressed ongoing concerns about her “inability to deliver positive business results for [Forest’s] products within [her] territory.” Sanguinetti took maternity leave in July 2008, and returned on January 6, 2009. On January 7, 2009, Toups gave Sanguinetti her first ever below satisfactory midyear review of 2.82.1 The evaluation expressed serious concerns about her sales results based on her near-bottom sales ranking for fiscal year 2008. On February 18, 2009, Toups gave Sanguinetti a field trip evaluation score of 2.72. The evaluation emphasized Sanguinetti’s national sales ranking continued to be near the bottom, and prescriptions written in her territory for a leading Forest product continued to lag. On February 20, 2009, Toups issued Sanguinetti a written warning, copied to Bonnie McDonald, Forest’s human resources director for field sales, based on Sanguinetti’s continued poor sales results. The warning stated “a failure on your part to improve to an ‘above standard’ rating” would result in “further disciplinary action . . . up

1 This covered the period from April 1, 2008 to October 1, 2008, and would have been given to her before January 2009, had she not been on maternity leave.

2 to probation and including termination.” On March 17, 2009, Sanguinetti filed a written complaint with McDonald, asserting Toups was discriminating against her for taking a maternity leave in 2008, and requesting a formal investigation. Sanguinetti’s complaint described conversations with Toups in which he alluded to the challenges of balancing work and family while raising multiple children. She described another discussion that occurred two weeks after she returned to work in which Toups pressed her about the need to generate more sales every day. When Sanguinetti defended the progress she had made in her brief time back in the field, Toups responded in an agitated manner: “ ‘Your family is affecting my money.’ ”2 On another occasion shortly after her return he told her she would have to “ ‘suffer the consequences’ ” for the time she had taken off. Sanguinetti’s April 2009 performance review for fiscal year 2009 reflected an overall score of 2.86. Her sales ranking continued to be close to the bottom nationally. The review faulted her for failing to persuade more physicians to write more prescriptions for Forest’s products, and not meeting the expectations outlined in the February 2009 warning letter. In April 2009, Sanguinetti asked Toups for a private room for a business trip to take place in late April, to ensure privacy when she pumped breast milk. The request was denied. In June 2009, Forest arranged for a regional sales trainer, Cormac McCaul, to ride with Sanguinetti and provide her with coaching and feedback. McCaul drafted a review of his field ride indicating several specific performance deficiencies. The tone of his report was highly critical.3 During his visit, McCaul made several comments to Sanguinetti she regarded as discriminatory. The first comment he made to her when they sat down to have lunch was, “I heard you had a baby nine months ago.” He also

2 Toups denied making this statement. 3 For example the review stated: “In light of your 11 years on the job, it is my opinion that you are underperforming and I saw a lack of initiative to change.” He wrote that she had made “numerous miss-steps” during time he accompanied her, “much of it tied back into your own initiative to learn your product and plan for your calls.” Sanguinetti dismissed most of McCaul’s purported observations during the field ride as fabrications.

3 commented he and his wife could barely handle working and having two children, and said, “ ‘I don’t know how you do it. How do you do it?’ ” He asked her questions about her personal life, such as who took care of her children and picked them up from their activities, that made her uncomfortable. Sanguinetti filed a second complaint of discrimination with McDonald in July 2009. In it, Sanguinetti explained why she believed Toups’s negative performance evaluations of her were bogus and unfair for numerous reasons, and how her sales rankings had been especially hard hit due to a decision by the Santa Clara Valley Medical Center in 2007 to pull one particular drug from its formulary in response to budget cuts. McDonald responded to the complaint in September 2009, explaining she had been unable substantiate Sanguinetti’s complaints of a hostile work environment or discrimination by Toups based on the number of children she had. On October 2, 2009, Sanguinetti received a field trip evaluation of 2.45 from Toups. Toups noted she had been in the bottom 50 percent of sales rankings for 10 consecutive quarters (i.e. since the first quarter of 2007). He noted she was expected to make an average of eight sales calls per day but according to her own records was making only three to four calls per day. Toups wrote: “You have continually expressed numerous reasons for your poor sales results . . . .

Free access — add to your briefcase to read the full text and ask questions with AI

Related

McDonnell Douglas Corp. v. Green
411 U.S. 792 (Supreme Court, 1973)
California Federal Savings & Loan Ass'n v. Guerra
479 U.S. 272 (Supreme Court, 1987)
Taylor, Carolyn v. Small, Lawrence M.
350 F.3d 1286 (D.C. Circuit, 2003)
Diann Grube v. Lau Industries, Inc.
257 F.3d 723 (Seventh Circuit, 2001)
Robert Rodriguez v. Airborne Express
265 F.3d 890 (Ninth Circuit, 2001)
Varjabedian v. City of Madera
572 P.2d 43 (California Supreme Court, 1977)
Turner v. Anheuser-Busch, Inc.
876 P.2d 1022 (California Supreme Court, 1994)
Yurick v. Superior Court
209 Cal. App. 3d 1116 (California Court of Appeal, 1989)
AARTS Productions, Inc. v. Crocker National Bank
179 Cal. App. 3d 1061 (California Court of Appeal, 1986)
Miller v. United Airlines, Inc.
174 Cal. App. 3d 878 (California Court of Appeal, 1985)
Sandhu v. Lockheed Missiles & Space Co.
26 Cal. App. 4th 846 (California Court of Appeal, 1994)
Okoli v. Lockheed Technical Operations Co.
36 Cal. App. 4th 1607 (California Court of Appeal, 1995)
DeJung v. Superior Court
169 Cal. App. 4th 533 (California Court of Appeal, 2008)
Mokler v. County of Orange
68 Cal. Rptr. 3d 568 (California Court of Appeal, 2007)
Trop v. Sony Pictures Entertainment, Inc.
29 Cal. Rptr. 3d 144 (California Court of Appeal, 2005)
Martin v. Lockheed Missiles & Space Co.
29 Cal. App. 4th 1718 (California Court of Appeal, 1994)

Cite This Page — Counsel Stack

Bluebook (online)
Sanguinetti v. Forest Laboratories CA1/1, Counsel Stack Legal Research, https://law.counselstack.com/opinion/sanguinetti-v-forest-laboratories-ca11-calctapp-2014.